The Economist @TheEconomist
Bavarian Nordic, the Danish firm that makes the monkeypox jab, is working around the clock to add capacity and expand its 800-strong workforce. Annual revenue is forecast to more than double this year, to $380m https://t.co/y04KL5zzik — PolitiTweet.org